Stay updated on Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.

Latest updates to the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page
- Check3 days agoChange DetectedThe page now reflects a newer ClinicalTrials.gov software/UI revision label (v3.5.3 instead of v3.5.2), which represents an internal version update rather than a change to the trial’s recorded information.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded Revision: v3.5.2; Removed Revision: v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedA new revision entry v3.5.0 was added to the history and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check46 days agoChange DetectedAdded revision entry v3.4.3 and removed v3.4.2 from the history.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded revision v3.4.2 to the record history and removed revision v3.4.1 from the history log. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1 on the page history; this is a minor system update with no impact on core content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efpeglenatide vs Dulaglutide in Type 2 Diabetes Clinical Trial page.